ACE I/D polymorphism and epidemiological findings for COVID-19: One year after the pandemic outbreak in Europe
- 4 June 2021
- journal article
- letter
- Published by Elsevier BV in Journal of Infection
- Vol. 83 (3), 381-412
- https://doi.org/10.1016/j.jinf.2021.06.002
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Distribution of the ACE1 D Allele in the Bosnian–Herzegovinian Population and its Possible Role in the Regional Epidemiological Picture of COVID-19Genetic Testing and Molecular Biomarkers, 2021
- Angiotensin converting enzyme genotypes and mortality from COVID-19: An ecological studyJournal of Infection, 2020
- SARS-CoV-2 infections and COVID-19 mortalities strongly correlate with ACE1 I/D genotypeGene, 2020
- ACE polymorphisms and COVID-19-related mortality in EuropeJournal of Molecular Medicine, 2020
- Could angiotensin-converting enzyme 1 I/D polymorphism be a modificator of COVID-19 response in different populations, diseases, and/or conditions?Journal of the Renin-Angiotensin-Aldosterone System, 2020
- COVID-19 infections are also affected by human ACE1 D/I polymorphismcclm, 2020
- The host’s angiotensin-converting enzyme polymorphism may explain epidemiological findings in COVID-19 infectionsClinica Chimica Acta; International Journal of Clinical Chemistry, 2020
- Angiotensin-converting enzyme deletion allele is beneficial for the longevity of EuropeansAGE, 2011